seed
Stage
1
Investors
About
Stately Bio develops regenerative medicines using an advanced machine learning cell imaging platform that measures live-cell behavior and maturation without labels, enabling novel cell therapies.
Explore Stately Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.